chr22-37755560-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039141.3(TRIOBP):​c.5588C>T​(p.Ala1863Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00222 in 1,613,978 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 14 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

12
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:8

Conservation

PhyloP100: 1.37

Publications

7 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013053089).
BP6
Variant 22-37755560-C-T is Benign according to our data. Variant chr22-37755560-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 177980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00192 (292/152332) while in subpopulation NFE AF = 0.00268 (182/68024). AF 95% confidence interval is 0.00236. There are 1 homozygotes in GnomAd4. There are 164 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.5588C>T p.Ala1863Val missense_variant Exon 15 of 24 ENST00000644935.1 NP_001034230.1 Q9H2D6-1
TRIOBPNM_007032.5 linkc.449C>T p.Ala150Val missense_variant Exon 5 of 14 NP_008963.3 Q9H2D6-7
TRIOBPNM_138632.2 linkc.449C>T p.Ala150Val missense_variant Exon 5 of 8 NP_619538.2 Q9H2D6-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.5588C>T p.Ala1863Val missense_variant Exon 15 of 24 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1

Frequencies

GnomAD3 genomes
AF:
0.00192
AC:
292
AN:
152214
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00715
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00268
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00230
AC:
578
AN:
251282
AF XY:
0.00217
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00518
Gnomad NFE exome
AF:
0.00319
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00225
AC:
3292
AN:
1461646
Hom.:
14
Cov.:
32
AF XY:
0.00226
AC XY:
1641
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00536
AC:
140
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000754
AC:
65
AN:
86256
European-Finnish (FIN)
AF:
0.00577
AC:
307
AN:
53220
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00238
AC:
2650
AN:
1111980
Other (OTH)
AF:
0.00159
AC:
96
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
178
355
533
710
888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152332
Hom.:
1
Cov.:
32
AF XY:
0.00220
AC XY:
164
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41570
American (AMR)
AF:
0.000392
AC:
6
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.00715
AC:
76
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00268
AC:
182
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00246
Hom.:
1
Bravo
AF:
0.00125
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00244
AC:
296
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00256
EpiControl
AF:
0.00284

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jul 02, 2019
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRIOBP: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 19, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala1863Val in exon 15 of TRIOBP: This variant is not expected to have clinical significance because it has been identified in 0.33% (220/66206) of European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs140528529). -

Jul 03, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meniere disease Uncertain:1
Jun 03, 2024
Center for Computational Biology & Bioinformatics, University of California, San Diego
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

TRIOBP-related disorder Benign:1
Jan 10, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;T;.;.;.;D;T;D
Eigen
Benign
0.15
Eigen_PC
Benign
0.032
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.97
.;D;.;D;D;D;D;D
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.013
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Benign
1.5
L;L;.;.;.;.;.;.
PhyloP100
1.4
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.3
D;.;D;D;.;D;D;D
REVEL
Uncertain
0.44
Sift
Uncertain
0.0010
D;.;D;D;.;D;D;D
Sift4G
Uncertain
0.0070
D;.;D;D;.;D;D;D
Polyphen
0.98
D;D;.;.;.;.;.;.
Vest4
0.67
MVP
0.89
MPC
0.46
ClinPred
0.023
T
GERP RS
2.8
Varity_R
0.28
gMVP
0.59
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140528529; hg19: chr22-38151567; COSMIC: COSV58526407; COSMIC: COSV58526407; API